345 related articles for article (PubMed ID: 15647607)
1. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
3. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
[TBL] [Abstract][Full Text] [Related]
4. Alterations in gastric mucosal lineages before or after acute oxyntic atrophy in gastrin receptor and H2 histamine receptor-deficient mice.
Aikou S; Fukushima Y; Ogawa M; Nozaki K; Saito T; Matsui T; Goldenring JR; Kaminishi M; Nomura S
Dig Dis Sci; 2009 Aug; 54(8):1625-35. PubMed ID: 19507031
[TBL] [Abstract][Full Text] [Related]
5. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
6. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
7. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.
Yamagata Y; Aikou S; Fukushima T; Kataoka H; Seto Y; Esumi H; Kaminishi M; Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1254-61. PubMed ID: 23064758
[TBL] [Abstract][Full Text] [Related]
8. Reversible drug-induced oxyntic atrophy in rats.
Goldenring JR; Ray GS; Coffey RJ; Meunier PC; Haley PJ; Barnes TB; Car BD
Gastroenterology; 2000 Jun; 118(6):1080-93. PubMed ID: 10833483
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
10. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
11. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Ogawa M; Nomura S; Car BD; Goldenring JR
Dig Dis Sci; 2006 Mar; 51(3):431-9. PubMed ID: 16614949
[TBL] [Abstract][Full Text] [Related]
13. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
14. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
15. Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions.
Minegishi Y; Suzuki H; Arakawa M; Fukushima Y; Masaoka T; Ishikawa T; Wright NA; Hibi T
J Pathol; 2007 Oct; 213(2):161-9. PubMed ID: 17763396
[TBL] [Abstract][Full Text] [Related]
16. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice.
Fukuhara S; Matsuzaki J; Tsugawa H; Masaoka T; Miyoshi S; Mori H; Fukushima Y; Yasui M; Kanai T; Suzuki H
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():53-9. PubMed ID: 25521734
[TBL] [Abstract][Full Text] [Related]
17. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
18. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
19. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
[TBL] [Abstract][Full Text] [Related]
20. Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors.
Karam SM; Tomasetto C; Rio MC
Gut; 2004 Oct; 53(10):1408-15. PubMed ID: 15361486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
